Opendata, web and dolomites

Miiskin SIGNED

ML-powered app and platform to identify skin changes over time

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Miiskin project word cloud

Explore the words cloud of the Miiskin project. It provides you a very rough idea of what is the project "Miiskin" about.

deaths    africa    moles    concentrated    miiskin    spotting    made    nevertheless    melanocytes    reduce    innovative    unlocking    detection       body    automatic    innovation    unprecise    mm    malignant    helping    commercial    caused    98    rate    responsible    previously    countries       efficient    mole    dermatologically    diagnose    clinical    endorsement    consuming    250    successful    highest    created    mostly    400    australia    competitive    close    denmark    app    melapp    supporting    norway    minimum    seal    tumour    232    photo    cancer    apps    south    melanoma    skin    node    bearing    market    monitor    position    artificial    acquired    quality    tool    lacking    time    survival    manually    intelligence    lymphatic    diagnosed    healthcare    poles    skinvision    originates    globally    treatment    healthy    people       worldwide    treating    patient    risk    certification    monitoring    thanks    doctor    identification    metastases    2030    ambition    teledermatology    25    mortality    expansion    sign   

Project "Miiskin" data sheet

The following table provides information about the project.

Coordinator
MIISKIN APS 

Organization address
address: FRUEBJERGVEJ 3
city: København O
postcode: 2100
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2020-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MIISKIN APS DK (København O) coordinator 50˙000.00

Map

 Project objective

Malignant Melanoma (MM) is a tumour which originates mostly in the skin melanocytes and is responsible for most deaths caused by skin cancer, due to the high risk of lymphatic metastases and expansion to other areas of the body. Globally, 232,000 people are diagnosed with MM every year, 90,000 of those concentrated in Europe. While early detection of melanoma has a 98% survival rate, late detection has only a 10-25% survival rate, with a mortality rate going from 3% in countries like Norway or Denmark to 6-7% in other areas close to the poles like South Africa or Australia. Treating MM cost to the healthcare system a minimum of €10,000 to €250,000€ per patient. People at high risk of developing MM or healthy people who has previously been diagnose with MM skin cancer have to regularly monitor their skin and moles for changes. Any skin/mole change can be an early sign of skin cancer and early detection of melanoma is crucial for successful treatment. Nevertheless, the process of spotting manually new changes in the skin can be highly time consuming and unprecise, as it is done manually or using commercial apps (MelApp, SkinVision) lacking clinical certification. We have created, Miiskin app as a supporting tool to help users to monitor skin changes over time with an innovative technology application based in artificial intelligence. Thanks to our innovation, we made the monitoring process more efficient and reliable, helping in the identification of new moles through automatic photo comparison. Moreover, Miiskin will be used as patient-doctor node fully unlocking the potential of teledermatology. Thanks to that we are the unique app worldwide bearing the dermatologically endorsement quality seal. We have already acquired a strong and highly competitive market position as well as the highest rate among Skin Cancer apps, involving more than 400,000 users worldwide. With this ambition we aim to reduce skin cancer mortality to 1% by 2030.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MIISKIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MIISKIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Cortx (2019)

Intelligent debt recovery platform.

Read More  

IMPACT (2019)

Improving DNA Analysis for Correct Healthcare

Read More  

MIGRATECH 4.0 (2019)

The revolution in micro-granulation technology for eco-friendly, production efficient, superior ceramic tiles

Read More